MAP7 and MUCL1 Are Biomarkers of Vitamin D3-Induced Tolerogenic Dendritic Cells in Multiple Sclerosis Patients

MAP7 and MUCL1 Are Biomarkers of Vitamin D3-Induced Tolerogenic Dendritic Cells in Multiple Sclerosis Patients

The administration of autologous tolerogenic dendritic cells (tolDC) has become a promising alternative for the treatment of autoimmune diseases, such as multiple sclerosis (MS). Specifically, the use of vitamin D3 for the generation of tolDC (vitD3-tolDC) constitutes one of the most widely studied...

Full description

Bibliographic Details
Main Authors: Juan Navarro-Barriuso, María José Mansilla, Bibiana Quirant-Sánchez, Alicia Ardiaca-Martínez, Aina Teniente-Serra, Silvia Presas-Rodríguez, Anja ten Brinke, Cristina Ramo-Tello, Eva M. Martínez-Cáceres
Format: Article
Language:English
Published: Frontiers Media S.A. 2019-06-01
Series:Frontiers in Immunology
Subjects:
tolerogenic dendritic cells
multiple sclerosis
biomarkers
vitamin D3
immune tolerance
Online Access:https://www.frontiersin.org/article/10.3389/fimmu.2019.01251/full

Internet

https://www.frontiersin.org/article/10.3389/fimmu.2019.01251/full

Similar Items